The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Unichem Laboratories Ltd

Unichem Laboratories Ltd

BSE 506690 · NSE UNICHEMLAB · ISIN INE351A01035 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹537.50

+1.25%

BSE close, 28 August 2026

Market cap

₹3,784.31 cr

7.0 cr shares · Micro cap

Free float

₹1,087.64 cr

as published

P/E · P/B

22.8× · 1.60×

EPS ₹23.62 · BV ₹335.94

FY25-26 rev / PAT

1,412.29 / 158.94

₹ cr, as filed

Filings, window

11

2 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹280.00 52-WK HIGH ₹685.95 ₹537.50 63% of range
Against 52-week high-21.6%
Against 52-week low+92.0%
Day change+1.25%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹23.62
Price / earnings22.76×
Price / book1.60×
Book value — derived, price ÷ P/B₹335.94
Return on equity7.05%
Operating margin10.20%
Net margin1.51%

Consistency check

P/B ÷ P/E, which must equal ROE
7.03%
ROE as published
7.05%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 366.27 5.53 0.79 10.20% 1.51%
Mar-26 · Q 356.24 -15.39 -2.19 6.27% -4.32%
FY25-26 1,412.29 158.94 22.57 24.09% 11.25%

Quarter on quarter

Revenue, quarter on quarter
+2.8%
Net profit, quarter on quarter
+135.9%
Operating margin, quarter on quarter
+393 bps

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
General3
AGM / EGM2
Board Meeting1
Clarification1
Newspaper Publication1
Trading Window1
Procedural sub-total9
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 2 selected · busiest 2026-08-11

Filing rhythm · the twelve most recent

2026-07-282026-09-24

SelectedProcedural

Filings

11 in the window · 16 earlier on record

  1. 24 September 2026 ·

    Trading Window

    Closure of Trading Window

    Notice of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 11 September 2026 ·

    General

    506690 - Extension Of The Exercise Period For The Options Granted And Vested Under Unichem Employee Stock Option Scheme 2018

    Extension of the Exercise period for the options granted and vested under Unichem Employee Stock Option Scheme 2018.

    Company Update / General View filing →

  3. 26 August 2026 ·

    General

    Significant Inc rease In The Volume Of Securities.

    Significant increase in the volume of securities.

    Company Update / General View filing →

  4. 26 August 2026 ·

    Clarification

    Clarification sought from Unichem Laboratories Ltd

    The Exchange has sought clarification from Unichem Laboratories Ltd on August 26, 2026, with reference to Movement in Volume. The reply is awaited.

    Company Update / Clarification

  5. 12 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Disclosure of Voting Results alongwith Scrutinizer's Report dated 12th August 2026.

    AGM/EGM / AGM View filing →

  6. 12 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Financial Results for the quarter ended June 30, 2026, published in the newspapers on August 12, 2026.

    Company Update / Newspaper Publication View filing →

  7. 11 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 63rd Annual General Meeting.

    AGM/EGM / AGM View filing →

  8. 11 August 2026 ·

    Results

    Q1 Financial Statement Of FY 2026-2027

    Pl. find enclosed financial statement of FY 2026-2027 (CFS & SFS)

    Result / Financial Results View filing →

  9. 11 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Unaudited Financial Statements (Consolidated & Standalone) for the first quarter ended 30th June 2026 alongwith Limited Review report by Auditors

    Board Meeting / Outcome of Board Meeting View filing →

  10. 29 July 2026 ·

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

    Disclosure u/r. 30 of SEBI (LODR), 2015

    Company Update / General View filing →

  11. 28 July 2026 ·

    Board Meeting

    Board Meeting Intimation for To Inter-Alia Consider And Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended 30Th June 2026.

    Unichem Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve The Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Unichem Laboratories Ltd · the 50 most recent filings